- Home
- CMMB vs TC Comparison
CMMB vs TC Comparison
Compare CMMB & TC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMMB
- TC
- Stock Information
- Founded
- CMMB 2004
- TC 2010
- Country
- CMMB Israel
- TC Cayman Islands
- Employees
- CMMB N/A
- TC N/A
- Industry
- CMMB Biotechnology: Pharmaceutical Preparations
- TC Business Services
- Sector
- CMMB Health Care
- TC Consumer Discretionary
- Exchange
- CMMB Nasdaq
- TC Nasdaq
- Market Cap
- CMMB 22.0M
- TC 26.0M
- IPO Year
- CMMB N/A
- TC 2018
- Fundamental
- Price
- CMMB $0.95
- TC $0.73
- Analyst Decision
- CMMB Strong Buy
- TC
- Analyst Count
- CMMB 2
- TC 0
- Target Price
- CMMB $8.50
- TC N/A
- AVG Volume (30 Days)
- CMMB 125.0K
- TC 35.4K
- Earning Date
- CMMB 08-20-2025
- TC 08-29-2025
- Dividend Yield
- CMMB N/A
- TC N/A
- EPS Growth
- CMMB N/A
- TC N/A
- EPS
- CMMB N/A
- TC N/A
- Revenue
- CMMB N/A
- TC $6,737,269.00
- Revenue This Year
- CMMB N/A
- TC N/A
- Revenue Next Year
- CMMB N/A
- TC N/A
- P/E Ratio
- CMMB N/A
- TC N/A
- Revenue Growth
- CMMB N/A
- TC N/A
- 52 Week Low
- CMMB $0.87
- TC $0.46
- 52 Week High
- CMMB $2.55
- TC $4.30
- Technical
- Relative Strength Index (RSI)
- CMMB 17.79
- TC 53.04
- Support Level
- CMMB $0.87
- TC $0.76
- Resistance Level
- CMMB $1.01
- TC $0.79
- Average True Range (ATR)
- CMMB 0.06
- TC 0.06
- MACD
- CMMB -0.01
- TC -0.00
- Stochastic Oscillator
- CMMB 23.78
- TC 52.94
About CMMB Chemomab Therapeutics Ltd.
Chemomab Therapeutics Ltd is a clinical-stage biotech company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs. The company's candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin, and lung fibrosis using a novel and differentiated mechanism of action. CM-101 has demonstrated the potential to treat multiple severe and life-threatening fibrotic and inflammatory diseases. It is advancing three Phase 2 clinical trials in parallel for CM-101, treating rare fibrotic conditions.
About TC TuanChe Limited
Token Cat Ltd is an omnichannel automotive marketplace in China. The company operates in one segment, providing auto shows, special promotion event services, virtual dealerships, online marketing services, and more. It organizes auto shows to facilitate transactions between consumers and auto dealers, which include auto dealers, automakers, and automotive service providers. It offers services through its online platform and offline events.